releases: https://www.mccaskill.senate.gov/media-center/news-releases/in-fight-to-keep-consumers-safe-mccaskill-pushes-fda-to-improve-process-for-reviewing-dietary-supplement-ingredients
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://www.mccaskill.senate.gov/media-center/news-releases/in-fight-to-keep-consumers-safe-mccaskill-pushes-fda-to-improve-process-for-reviewing-dietary-supplement-ingredients | In Fight to Keep Consumers Safe, McCaskill Pushes FDA to Improve Process for Reviewing Dietary Supplement Ingredients | 2016-12-15 | 2016 | 2016-12 | Democrat | House | MO | Claire McCaskill | M001170 | www.mccaskill.senate.gov | legacy | In Fight to Keep Consumers Safe, McCaskill Pushes FDA to Improve Process for Reviewing Dietary Supplement Ingredients Senator outlines need for transparency and enforcement in letter to FDA Commissioner, cites frustration at bureaucratic delays Thursday, December 15, 2016 WASHINGTON – U.S. Senator Claire McCaskill wrote to the government’s top food and drug safety official as part of a years-long push to ensure that dietary supplements available to American consumers are safe and that enforcement action is quickly taken against scam artists who break the law and endanger consumers. After an unexplained five-year delay, the Food and Drug Administration (FDA) released draft guidance for manufacturers outlining the process for including new ingredients in dietary supplements. This draft guidance provides much needed direction for manufacturers on the testing, safety standards, and manufacturing processes required by FDA for new dietary ingredients. In a letter to FDA commissioner Robert Califf, McCaskill outlined three areas of the draft guidance that need improvement to ensure that manufacturers understand their responsibilities, and that consumers remain safe, including transparency about the ingredients for consumers and healthcare professionals and the need to take aggressive enforcement actions against any manufacturers making and selling unsafe and illicit supplements. After years of advocacy to ensure American consumers are protected in the dietary supplement industry, McCaskill urged the FDA to include these consumer protections in their guidance ahead of its final release. “Given the ongoing public safety concerns involved, I urge the FDA to quickly consider this comment and others and finalize its guidance as soon as possible. American consumers cannot afford to wait for another five years,” McCaskill wrote. McCaskill, the top-ranking Democrat on the Senate Special Committee on Aging, had previously written to ten medical associations asking for any policies they have developed for when and how physicians assess dietary supplement use in patients prior to starting treatment. Last year, McCaskill—a former Missouri State Auditor and courtroom prosecutor—sent letters to 15 retailers inquiring about their policies concerning dietary supplements and what they do to prevent the sale of harmful or fraudulently marketed products in their stores, on their websites and at shows. This inquiry was in response to the discovery of products such as Brain Armor, which has since been removed from the Amazon website, that made false claims about their ability to enhance memory and treat dementia. As past Chairman of the Senate’s Consumer Protection Subcommittee, McCaskill has also examined misleading and false claims made by makers of weight-loss products. A copy of McCaskill’s letter to FDA Commissioner Califf is available online HERE. Visit mccaskill.senate.gov/consumers to learn more about McCaskill’s fight to strengthen protections for American consumers. ### Print Email Tweet | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |